Adalimumab for treating inflammatory conditions
Agency for Care Effectiveness (ACE)
Record ID 32018002557
English
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/details/adalimumab-for-treating-inflammatory-conditions
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Arthritis, Rheumatoid
- Spondylitis, Ankylosing
- Arthritis, Psoriatic
- Psoriasis
- Colitis, Ulcerative
- Crohn Disease
- Hidradenitis Suppurativa
- Adalimumab
- Inflammatory Bowel Diseases
- Antirheumatic Agents
- Tumor Necrosis Factor Inhibitors
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.